首页> 中国专利> 治疗耳源性眩晕的药物

治疗耳源性眩晕的药物

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明公开了一种治疗耳源性眩晕的药物，由下述重量配比的原料制成：酸枣仁10-30份、柏子仁10-30份、山药20-30份、当归10-20份、五味子10-20份、龙眼肉20-40份、白蒺藜15-30份、天麻10-20份。本发明是在传统中医理论和临床实践基础上，精选出8种原料药进行配比，用于治疗耳源性眩晕，其具有起效快、症状缓解彻底、不易复发的特点。而且本发明药物原料易得，成本低，制备方便，便于治疗。

著录项

公开/公告号CN105362716A

专利类型发明专利
公开/公告日2016-03-02

原文格式PDF
申请/专利权人唐晓军;
展开▼

申请/专利号CN201410434534.5
发明设计人唐晓军;
展开▼

申请日2014-08-29
分类号A61K36/8988;A61P1/08;A61P27/16;
代理机构桂林市华杰专利商标事务所有限责任公司;
代理人杨雪梅
地址 541100 广西壮族自治区桂林市临桂区金水路锦榕花园
入库时间 2023-12-18 14:26:07

法律信息

法律状态公告日

法律状态信息

法律状态
2018-12-04

发明专利申请公布后的撤回 IPC(主分类):A61K36/8988 申请公布日:20160302 申请日:20140829

发明专利申请公布后的撤回
2016-03-30

实质审查的生效 IPC(主分类):A61K36/8988 申请日:20140829

实质审查的生效
2016-03-02

公开

公开

相似文献

专利
中文文献
外文文献

1. 治疗耳源性眩晕的药物 [P] . 中国专利： CN105362716A . 2016-03-02
2. 治疗耳源性眩晕、颈源性眩晕的药物及其制备方法 [P] . 中国专利： CN100345587C . 2007.10.31
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. the pharmaceutical method and composition for the prevention or treatment of a disease or an autoimmune or infectious condition, pharmaceutical method and composition for the prevention or treatment of a disease or a condition of blood, pharmaceutical method and composition to modulate the formation of blood cells, Pharmaceutical method and composition to intensify peripheral mobilisation of stem cell, method and pharmaceutical composition for the prevention or treatment of a disease or metabolic condition,Pharmaceutical method and composition for the prevention or treatment of conditions associated with myeloablive chemotherapy doses supported by autologous bone marrow transplantation or peripheral blood stem cells (asct) or allogeneic bone marrow transplantation (bmt),Pharmaceutical method and composition to increase the effect of a stimulating factor in blood cells, method and pharmaceutical composition to intensify the colonization of donor blood stem cells in a myeloablated recept [P] . BRPI0507822A . 2007-07-10

机译：用于预防或治疗疾病或自身免疫或感染性疾病的药物方法和组合物，用于预防或治疗疾病或血液疾病的药物方法和组合物，调节血细胞形成的药物方法和组合物，增强干细胞外周动员的药物方法和组合物，用于预防或治疗疾病或代谢病的方法和药物组合物，用于预防或治疗与自体骨髓移植支持的骨髓活性化疗剂量有关的病症的药物方法和组合物或外周血干细胞（asct）或同种异体骨髓移植（bmt），增加刺激因子在血细胞中的作用的药物方法和组合物，增强骨髓脱钙受体中供体血干细胞定植的方法和药物组合物
5. Pharmaceutical composition for preventing and healing epithelial lesions, immunomodulatory pharmaceutical composition, pharmaceutical composition for treating toxoplasmosis, pharmaceutical composition, insecticidal composition, insecticide, use of km + lectin to treat scarring, use of km + lectin to treat toxoplasmosis, use of km + lectin to prepare medicine to treat toxoplasmosis, use of km + lectin to prepare immunomodulatory drug, use of km + lectin to prepare antibacterial drug, use of km + lectin to prepare antiviral drug, expression method, DNA vector, recombinant organism, nucleotide sequence, proteins, antibodies and plasmids [P] . BR0301547A . 2005-03-22

机译：用于预防和治愈上皮病变的药物组合物，免疫调节药物组合物，用于治疗弓形虫病的药物组合物，药物组合物，杀虫组合物，杀虫剂，使用km +凝集素治疗疤痕，使用km +凝集素治疗弓形虫病，使用km +凝集素准备治疗弓形虫病的药物，使用km +凝集素制备免疫调节药物，使用km +凝集素制备抗菌药物，使用km +凝集素制备抗病毒药物，表达方法，DNA载体，重组生物，核苷酸序列，蛋白质，抗体和质粒